ContributorsPublishersAdvertisers

Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation

Nature.com
 2021-10-11

Cover picture for the articleCovid-19 has shown to affect patients with hematological malignancies (HMs) more severely than the general population, with an estimated mortality rate of 33"“37% [1,2,3]. In these patients, the rate of antibody response against SARS-CoV-2 infection has been estimated to be 69% [4]. At present, the anti-SARS-CoV-2 vaccination represents the...

www.nature.com

Comments / 0

Comments / 0